Robert Langer's Net Worth

$1.16 Billion

Who is Robert Langer?

Robert Langer has an estimated net worth of $1.16 Billion. This is based on reported shares across multiple companies, which include Moderna, Inc., WYETH, Fibrocell Science, Inc., DNIB UNWIND, INC., Seer, Inc., SQZ Biotechnologies Co, SELECTA BIOSCIENCES INC, Rubius Therapeutics, Inc., Lyra Therapeutics, Inc., Kala Pharmaceuticals, Inc., INVIVO THERAPEUTICS HOLDINGS CORP., Frequency Therapeutics, Inc., MOMENTA PHARMACEUTICALS INC, Ocata Therapeutics, Inc., MILLIPORE CORP /MA, Abpro Corp, ALSERES PHARMACEUTICALS INC /DE, and Echo Therapeutics, Inc..

SEC CIK

Robert Langer's CIK is 0001239757

Past Insider Trading and Trends

2007 was Robert Langer's most active year for acquiring shares with 12 total transactions. Robert Langer's most active month to acquire stocks was the month of May. 2013 was Robert Langer's most active year for disposing of shares, totalling 33 transactions. Robert Langer's most active month to dispose stocks was the month of April. 2005 saw Robert Langer paying a total of $257,440.00 for 104,200 shares, this is the most they've acquired in one year. In 2016 Robert Langer cashed out on 112,250 shares for a total of $433,500.00, their largest year based on trade value.